Allergies - Xconomy

by in

Entry	Author	Date	Location
New Startup Vedanta Harnesses Microbial Activities to Boost Healthy Immune Function	Ryan McBride	12/23/10	Boston
Omeros Nabs $25M from Paul Allen, State Life Sciences Fund to Pursue Elusive Drug Targets	Luke Timmerman	10/25/10	Seattle
Healthcare Venture Investment Deals Climbing Back, Halozyme Sells Its Diagnostics Business, Dry Lab Biotechs Cluster in Carmel Valley, & More San Diego Life Sciences News	Bruce V. Bigelow	10/14/10	San Diego
VentiRx, With Venti-Sized Ambition to Treat (and Maybe Prevent) Allergies, Passes First Big Test	Luke Timmerman	10/07/10	Seattle
DataSphere and Halosource Get Funded, Sage Signs Up Pfizer, Zymo Raises $90M, & More Seattle-Area Deals News	Gregory T. Huang	01/12/10	Seattle
VentiRx Nabs $25M for Cancer, Allergy Drugs	Luke Timmerman	01/12/10	San Diego
VentiRx, Evangelist for Lean, Mean Virtual Way, Makes Progress With Cancer, Allergy Drugs	Luke Timmerman	09/17/09	Seattle
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment	Luke Timmerman	06/09/09	Boston
Supersized Ambitions: VentiRx Aims to be Extra-Large Player in Cancer, Allergy Medicines	Luke Timmerman	01/07/09	Seattle
Meritage Pharma Aims to Develop Drug to Reduce Swelling in the Food Pipe	Luke Timmerman	12/03/08	San Diego
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration	Luke Timmerman	09/02/08	Boston
Page 1 of 1

Xconomy National